4.3 Article

Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-D-aspartate receptor encephalitis

期刊

JOURNAL OF NEUROIMMUNOLOGY
卷 297, 期 -, 页码 141-147

出版社

ELSEVIER
DOI: 10.1016/j.jneuroim.2016.05.023

关键词

Cytokine; Autoimmune encephalitis; NMDAR; LGI1; IL-17A; IL-6; CXCL13

资金

  1. Seoul National University Hospital Research Fund [25-2014-0040, 03-2015-0430]
  2. Yuhan Corporation, South Korea [06-2015-1690]
  3. Ildong Pharmaceutical Co., South Korea [06-2013-0950]
  4. Seoul National University Hospital [2015-2848]

向作者/读者索取更多资源

The aim of this study was to compare serum and cerebrospinal fluid (CSF) cytokine/chemokine levels between anti-NMDAR and anti-LGI1 encephalitis patients. Samples from fourteen anti-NMDAR encephalitis patients, ten anti-LGI1 encephalitis patients, and ten controls were analyzed for the following cytokines/chemokines: IL-1b, IL-2, IL-4, IL-5, IL-6,IL-10, IL-12, IL-13, IL-17A, IL-23, GM-CSF, IFN-gamma, TNF-alpha, and CXCL13. Compared with controls, CSF IL-17A, IL-6 and CXCL13 were elevated in anti-NMDAR encephalitis patients (post-hoc p-values 0.002, 0.011, and 0.011, respectively) but not in anti-LGI1 encephalitis patients. In the serum, only IL-2 was increased in anti-NMDAR encephalitis. Intrathecal IL-17/IL-6 activation is a characteristic of anti-NMDAR encephalitis. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据